< Back to situations

[ORGANIZATION]

Hyrnuo

Featured in 1 tracked story · first seen

Situations

[ACTIVE] [BUSINESS] [US] [CN] [JP]

Bayer Hyrnuo regulatory approvals for lung cancer

2 clusters · 4 sources · last updated

Latest: Bayer receives US FDA approval for lung cancer drug Hyrnuo

Bayer has secured regulatory approvals for its lung cancer drug, Hyrnuo (sevabertinib), in major international markets. In August 2026, Japan’s Ministry of Health, Labour and Welfare approved the therapy for patients w